• Something wrong with this record ?

Silybin and its congeners: from traditional medicine to molecular effects

V. Křen, K. Valentová

. 2022 ; 39 (6) : 1264-1281. [pub] 20220622

Language English Country Great Britain

Document type Journal Article, Review

Covering: 2015 up to 2022 (Feb)Silymarin, an extract of milk thistle (Silybum marianum) fruits, has been used in various medicinal applications since ancient times. A major component of silymarin is the flavonolignan silybin and its relatives isosilybin, silychristin, silydianin, 2,3-dehydrosilybin, and some others. Except for silydianin, they occur in nature as two stereomers. This review focuses on recent developments in chemistry, biosynthesis, modern advanced analytical methods, and transformations of flavonolignans specifically reflecting their chirality. Recently described chemotypes of S. marianum, but also the newest findings regarding the pharmacokinetics, hepatoprotective, antiviral, neuroprotective, and cardioprotective activity, modulation of endocrine functions, modulation of multidrug resistance, and safety of flavonolignans are discussed. A growing number of studies show that the respective diastereomers of flavonolignans have significantly different activities in anisotropic biological systems. Moreover, it is now clear that flavonolignans do not act as antioxidants in vivo, but as specific ligands of biological targets and therefore their chirality is crucial. Many controversies often arise, mainly due to the non-standard composition of this phytopreparation, the use of various undefined mixtures, the misattribution of silymarin vs. silybin, and also the failure to consider the chemistry of the respective components of silymarin.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017963
003      
CZ-PrNML
005      
20220804134503.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1039/d2np00013j $2 doi
035    __
$a (PubMed)35510639
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Křen, Vladimír $u Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, CZ 14220, Czech Republic. kren@biomed.cas.cz $1 https://orcid.org/0000000210914020 $7 xx0070803
245    10
$a Silybin and its congeners: from traditional medicine to molecular effects / $c V. Křen, K. Valentová
520    9_
$a Covering: 2015 up to 2022 (Feb)Silymarin, an extract of milk thistle (Silybum marianum) fruits, has been used in various medicinal applications since ancient times. A major component of silymarin is the flavonolignan silybin and its relatives isosilybin, silychristin, silydianin, 2,3-dehydrosilybin, and some others. Except for silydianin, they occur in nature as two stereomers. This review focuses on recent developments in chemistry, biosynthesis, modern advanced analytical methods, and transformations of flavonolignans specifically reflecting their chirality. Recently described chemotypes of S. marianum, but also the newest findings regarding the pharmacokinetics, hepatoprotective, antiviral, neuroprotective, and cardioprotective activity, modulation of endocrine functions, modulation of multidrug resistance, and safety of flavonolignans are discussed. A growing number of studies show that the respective diastereomers of flavonolignans have significantly different activities in anisotropic biological systems. Moreover, it is now clear that flavonolignans do not act as antioxidants in vivo, but as specific ligands of biological targets and therefore their chirality is crucial. Many controversies often arise, mainly due to the non-standard composition of this phytopreparation, the use of various undefined mixtures, the misattribution of silymarin vs. silybin, and also the failure to consider the chemistry of the respective components of silymarin.
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a tradiční lékařství $7 D008519
650    _2
$a ostropestřec mariánský $x chemie $7 D020944
650    _2
$a silibinin $7 D000077385
650    12
$a silymarin $x chemie $x farmakologie $7 D012838
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Valentová, Kateřina $u Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, CZ 14220, Czech Republic. kren@biomed.cas.cz $1 https://orcid.org/0000000277145350 $7 xx0034397
773    0_
$w MED00005450 $t Natural product reports $x 1460-4752 $g Roč. 39, č. 6 (2022), s. 1264-1281
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35510639 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134456 $b ABA008
999    __
$a ok $b bmc $g 1821854 $s 1169206
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 39 $c 6 $d 1264-1281 $e 20220622 $i 1460-4752 $m Natural product reports $n Nat Prod Rep $x MED00005450
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...